Article
Population-specific variations in KCNH2 predispose patients to delayed ventricular repolarization upon dihydroartemisinin-piperaquine therapy.
Antimicrobial agents and chemotherapy - 2 May 2024
Camara Mahamadou D, Zhou Yitian, Dara Antoine, Tékété Mamadou M, Nóbrega de Sousa Taís, Sissoko Sékou, Dembélé Laurent, Ouologuem Nouhoun, Hamidou Togo Amadou, Alhousseini Mohamed L, Fofana Bakary, Sagara Issaka, Djimde Abdoulaye A, Gil Pedro J, Lauschke Volker M
Abstract excerpt
Dihydroartemisinin-piperaquine is efficacious for the treatment of uncomplicated malaria and its use is increasing globally. Despite the positive results in fighting malaria, inhibition of the Kv11.1 channel (hERG; encoded by the KCNH2 gene) by piperaquine has raised concerns about cardiac safety. Whether genetic factors could modulate the risk of piperaquine-mediated QT prolongations remained unclear. Here, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
